Ambulatory blood pressure monitoring trumps estimated glomerular filtration rate in predicting cardiovascular risk in low-risk populations

Hypertension

Volumn 61, Issue 1, 2013, Pages 14-15

  Agarwal, Rajiv ^a,b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE MONITORING; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CREATININE BLOOD LEVEL; DIABETES MELLITUS; FOLLOW UP; FRAMINGHAM RISK SCORE; GLOMERULUS FILTRATION RATE; HUMAN; ISCHEMIC HEART DISEASE; KIDNEY INJURY; LOW RISK POPULATION; META ANALYSIS (TOPIC); MORBIDITY; NOTE; PREVALENCE; PRIORITY JOURNAL; PROTEINURIA; RISK REDUCTION; SMOKING; SYSTOLIC BLOOD PRESSURE;

BLOOD PRESSURE; CARDIOVASCULAR DISEASES; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; MALE;

EID: 84871622223     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.111.00053     Document Type: Note

References (12)

1. Kannel WB, Dawber TR, Kagan A, Revotskie N, Stokes J 3rd. Factors of risk in the development of coronary heart disease-six year follow-up experience. The Framingham Study. Ann Intern Med. 1961;55:33-50.
2. Grundy SM, D'Agostino Sr RB, Mosca L, Burke GL, Wilson PW, Rader DJ, Cleeman JI, Roccella EJ, Cutler JA, Friedman LM. Cardiovascular risk assessment based on US cohort studies: fndings from a National Heart, Lung, and Blood institute workshop. Circulation. 2001;104:491-496. (Pubitemid 32678283)
3. Grundy SM. New cholesterol guidelines emphasize risk assessment. Am J Manag Care. 2002; Suppl:1, 3.
4. Wang TJ, Gona P, Larson MG, Tofer GH, Levy D, Newton-Cheh C, Jacques PF, Rifai N, Selhub J, Robins SJ, Benjamin EJ, D'Agostino RB, Vasan RS. Multiple biomarkers for the prediction of frst major cardiovascular events and death. N Engl J Med. 2006;355:2631-2639. (Pubitemid 44969122)
5. Boggia J, Thijs L, Li Y, et al; International Database on Ambulatory blood pressure in relation to Cardiovascular Outcomes (IDACO) Investigators. Risk stratifcation by 24-hour ambulatory blood pressure and estimated glomerular fltration rate in 5322 subjects from 11 populations. Hypertension. 2013;61:18-26.
6. Pencina MJ, D'Agostino RB, Pencina KM, Janssens AC, Greenland P. Interpreting incremental value of markers added to risk prediction models. Am J Epidemiol. 2012;176:473-481.
7. Wright JT Jr, Bakris G, Greene T, et al African American Study of Kidney Disease and Hypertension Study Group. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. JAMA. 2002;288:2421-2431. (Pubitemid 35340538)
8. Klahr S, Levey AS, Beck GJ, Caggiula AW, Hunsicker L, Kusek JW, Striker G. The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modifcation of Diet in Renal Disease Study Group. N Engl J Med. 1994;330:877-884. (Pubitemid 24094966)
9. Ruggenenti P, Perna A, Loriga G, et al; REIN-2 Study Group. Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomised controlled trial. Lancet. 2005;365:939-946. (Pubitemid 41071427)
10. Agarwal R. Blood pressure goal in chronic kidney disease: what is the evidence? Curr Opin Nephrol Hypertens. 2011;20:229-232.
11. Bangash F, Agarwal R. Masked hypertension and white-coat hypertension in chronic kidney disease: a meta-analysis. Clin J Am Soc Nephrol. 2009;4:656-664.
12. Pogue V, Rahman M, Lipkowitz M, Toto R, Miller E, Faulkner M, Rostand S, Hiremath L, Sika M, Kendrick C, Hu B, Greene T, Appel L, Phillips RA; African American Study of Kidney Disease and Hypertension Collaborative Research Group. Disparate estimates of hypertension control from ambulatory and clinic blood pressure measurements in hypertensive kidney disease. Hypertension. 2009;53:20-27.